跳至主要内容
临床试验/CTRI/2022/08/045036
CTRI/2022/08/045036尚未招募未知

Evaluation of prescription pattern and effectiveness of drugs used in Attention deficit hyperactivity disorder (ADHD)at a tertiary care hospital. - ADHD

Dr Dnyaneshwar G Kurle0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • A. Criteria for assessing prescription pattern, adverse drug reaction, awareness, cost:
  • 1. Patient with the age less than 16 years diagnosed with ADHD according DSM 5 of
  • either sex will be included.
  • 2. Patients receiving drug treatment for ADHD.
  • 3. Patients & legal authorized representative willing to give informed consent &
  • participate in the study.
  • Inclusion criteria for assessing effectiveness of drugs used in ADHD:
  • 1. Patient with the age from 6 to 16 years diagnosed with ADHD according DSM 5 of
  • either sex will be included.
  • 2. Patients receiving single drug either methylphenidate or atomoxetine will be
  • 3. Patients & legal authorized representative willing to give informed consent &
  • participate in the study.
  • 4. Patient who are able to understand and do the computerised psychometric test

排除标准

  • Criteria for assessing prescription pattern, adverse drug reaction, awareness, cost:
  • Patient not satisfying inclusion criteria will be excluded from the study.
  • Criteria for assessing effectiveness of drugs used in ADHD:
  • 1. Patients with other known neurological or gross organic diseases or other psychiatric
  • disorder or substance abuse.
  • 2. Patient taking psychoactive medications other than the study drugs.
  • 3. Patients with motor tics.
  • 4. Patient who are not able to understand or follow the instructions for doing the tes

研究者

发起方
Dr Dnyaneshwar G Kurle

相似试验

To see prescription patterns and effectiveness of... | 临床试验